$ARX

Accelerant Shares Surge 43% On Thoma Bravo Buyout Deal

Accelerant Holdings (ARX) shares rose about 43% after the company said it has a definitive agreement to be acquired by Thoma Bravo in an all-cash deal worth more than $4 billion. ARX was trading around $19.52, up $5.91, after opening near $19.61 versus a prior close of $13.61.

Original reporting
Published Aug 13, 2026, 5:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 5:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Accelerant Shares Surge 43% On Thoma Bravo Buyout Deal — source image
Decision brief

The 30-second read

$ARXBullishHigh
01

Why it matters

The disclosure is a takeover catalyst that typically drives rapid repricing and can shift trading from fundamentals to deal mechanics, including completion risk and potential arbitrage behavior.

02

Market read

Traders can act on a fresh, definitive M&A announcement with immediate price impact and deal-completion risk considerations.

03

What to watch

The article does not provide deal price per share, expected closing timeline, or any stated conditions, which are key for spread trading and downside risk assessment.

Relevance 9/10Novelty 9/10Timing: today, after-hours/regular-session reaction to a newly announced definitive buyout

Background

Accelerant Holdings announced a definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valued at more than $4B.

Company-level read

Ticker impact

$ARXBullishHigh confidence
Context

Accelerant Holdings (ARX) shares jumped 43% after announcing a definitive all-cash Thoma Bravo buyout valued at over $4B.

Expected impact

Near-term upside bias versus pre-deal levels, with volatility tied to deal closing risk and potential arbitrage dynamics.

Evidence & confidence

The article reports a definitive acquisition agreement and the stock’s same-day surge, indicating the market is repricing on deal terms rather than incremental operating news.

Market effects

Could modestly lift sentiment for specialty insurance M&A appetite, though the article is company-specific.

Primarily US-focused via NYSE-listed ARX; limited spillover implied.

Deal is large in absolute terms but described as private-equity acquisition, with no explicit cross-border operational impact mentioned.

Counterpoint

A large same-day spike can overshoot if closing conditions, regulatory approvals, or financing details introduce uncertainty, making post-announcement pullbacks possible.

Key entities

  • Accelerant Holdings

    NYSE-listed specialty insurance company whose shares surged after announcing a definitive all-cash buyout agreement.

  • Thoma Bravo

    Private equity firm acquiring Accelerant Holdings in the all-cash transaction described.

Related articles

$ARXHighAI 9/10

Accelerant To Be Acquired By Thoma Bravo

Accelerant Holdings (ARX) agreed to be acquired by Thoma Bravo in an all-cash deal valued at over $4 billion. Accelerant shareholders will receive $20.25 per share, a 49% premium to Aug. 12’s close. The deal is expected to close in 1H 2027 and take the firm private. ARX shares rose premarket.

$ARXMedAI 8/10

Accelerant Holdings (ARX): Results of Operations and Financial Condition

Accelerant Holdings (ARX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d286225dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Accelerant Announces Second Quarter 2026 Results Accelerant Cancels Earnings Conference Call Following Announcement of Agreement with Thoma Bravo to Become a Private Company Second Quarter 2026 Results • Exchange Written Pr

$ARXMed

ARX: Q2 2026 delivered robust operational and financial results, with the Shell acquisition progressing

Less than 1 min read Q2 2026 saw strong production growth and higher realized prices, driving a 20% year-over-year increase in funds from operations and a 94% rise in free funds flow per share. Net income declined 9% per share due to lower risk management gains and higher costs. The pending $22 billion Shell acquisition remains on track. Original document: ARC Resources Ltd. [ARX] Interim report — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies.

$ARXMed

ARX: Q2 2026 delivered robust production and cash flow as the $22B Shell acquisition advances

Less than 1 min read Q2 2026 saw 9% year-over-year production growth and strong cash flow, with $816 million in funds from operations and $349 million in free funds flow. The $22 billion Shell acquisition is progressing, with closing expected in Q3 2026. Original document: ARC Resources Ltd. [ARX] Earnings Release — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.